Azapetine

DB13727ExperimentalSmall molecule

Azapetine: Overview.

Mechanism: Pharmacologically active on Alpha-1 adrenergic receptors, Alpha-2 adrenergic receptors, and Alpha adrenergic receptor
Curator reviewed
Formula / weight: C₁₇H₁₇N · 235.33 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyNYGHGTMKALXFIA-UHFFFAOYSA-NSMILESC=CCN1CC2=CC=CC=C2C2=CC=CC=C2C1

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1ATC codeIncluding every combination product, plus 2 drug categories

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Azapetine, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.